Literature DB >> 20348956

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

Lambertus A Kiemeney1, Patrick Sulem, Soren Besenbacher, Sita H Vermeulen, Asgeir Sigurdsson, Gudmar Thorleifsson, Daniel F Gudbjartsson, Simon N Stacey, Julius Gudmundsson, Carlo Zanon, Jelena Kostic, Gisli Masson, Hjordis Bjarnason, Stefan T Palsson, Oskar B Skarphedinsson, Sigurjon A Gudjonsson, J Alfred Witjes, Anne J Grotenhuis, Gerald W Verhaegh, D Timothy Bishop, Sei Chung Sak, Ananya Choudhury, Faye Elliott, Jennifer H Barrett, Carolyn D Hurst, Petra J de Verdier, Charlotta Ryk, Peter Rudnai, Eugene Gurzau, Kvetoslava Koppova, Paolo Vineis, Silvia Polidoro, Simonetta Guarrera, Carlotta Sacerdote, Marcello Campagna, Donatella Placidi, Cecilia Arici, Maurice P Zeegers, Eliane Kellen, Berta Saez Gutierrez, José I Sanz-Velez, Manuel Sanchez-Zalabardo, Gabriel Valdivia, Maria D Garcia-Prats, Jan G Hengstler, Meinolf Blaszkewicz, Holger Dietrich, Roel A Ophoff, Leonard H van den Berg, Kristin Alexiusdottir, Kristleifur Kristjansson, Gudmundur Geirsson, Sigfus Nikulasson, Vigdis Petursdottir, Augustine Kong, Thorgeir Thorgeirsson, N Aydin Mungan, Annika Lindblom, Michael A van Es, Stefano Porru, Frank Buntinx, Klaus Golka, José I Mayordomo, Rajiv Kumar, Giuseppe Matullo, Gunnar Steineck, Anne E Kiltie, Katja K H Aben, Eirikur Jonsson, Unnur Thorsteinsdottir, Margaret A Knowles, Thorunn Rafnar, Kari Stefansson.   

Abstract

Previously, we reported germline DNA variants associated with risk of urinary bladder cancer (UBC) in Dutch and Icelandic subjects. Here we expanded the Icelandic sample set and tested the top 20 markers from the combined analysis in several European case-control sample sets, with a total of 4,739 cases and 45,549 controls. The T allele of rs798766 on 4p16.3 was found to associate with UBC (odds ratio = 1.24, P = 9.9 x 10(-12)). rs798766 is located in an intron of TACC3, 70 kb from FGFR3, which often harbors activating somatic mutations in low-grade, noninvasive UBC. Notably, rs798766[T] shows stronger association with low-grade and low-stage UBC than with more aggressive forms of the disease and is associated with higher risk of recurrence in low-grade stage Ta tumors. The frequency of rs798766[T] is higher in Ta tumors that carry an activating mutation in FGFR3 than in Ta tumors with wild-type FGFR3. Our results show a link between germline variants, somatic mutations of FGFR3 and risk of UBC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348956      PMCID: PMC2923020          DOI: 10.1038/ng.558

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  26 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?

Authors:  Cristiane Murta-Nascimento; Debra T Silverman; Manolis Kogevinas; Montserrat García-Closas; Nathaniel Rothman; Adonina Tardón; Reina García-Closas; Consol Serra; Alfredo Carrato; Cristina Villanueva; Mustafa Dosemeci; Francisco X Real; Núria Malats
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

Review 3.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

4.  A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine.

Authors:  Johanna M M van Oers; Irene Lurkin; Antonius J A van Exsel; Yvette Nijsen; Bas W G van Rhijn; Madelon N M van der Aa; Ellen C Zwarthoff
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

5.  Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.

Authors:  C Billerey; D Chopin; M H Aubriot-Lorton; D Ricol; S Gil Diez de Medina; B Van Rhijn; M P Bralet; M A Lefrere-Belda; J B Lahaye; C C Abbou; J Bonaventure; E S Zafrani; T van der Kwast; J P Thiery; F Radvanyi
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

6.  Familial aggregation of urothelial cell carcinoma.

Authors:  Katja K H Aben; J Alfred Witjes; Mark P Schoenberg; Christina Hulsbergen-van de Kaa; André L M Verbeek; Lambertus A L M Kiemeney
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

7.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

8.  Distinct microRNA alterations characterize high- and low-grade bladder cancer.

Authors:  James W F Catto; Saiful Miah; Helen C Owen; Helen Bryant; Katie Myers; Ewa Dudziec; Stéphane Larré; Marta Milo; Ishtiaq Rehman; Derek J Rosario; Erica Di Martino; Margaret A Knowles; Mark Meuth; Adrian L Harris; Freddie C Hamdy
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

9.  Detection of sharing by descent, long-range phasing and haplotype imputation.

Authors:  Augustine Kong; Gisli Masson; Michael L Frigge; Arnaldur Gylfason; Pasha Zusmanovich; Gudmar Thorleifsson; Pall I Olason; Andres Ingason; Stacy Steinberg; Thorunn Rafnar; Patrick Sulem; Magali Mouy; Frosti Jonsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hreinn Stefansson; Kari Stefansson
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

10.  FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer.

Authors:  D C Tomlinson; O Baldo; P Harnden; M A Knowles
Journal:  J Pathol       Date:  2007-09       Impact factor: 7.996

View more
  76 in total

1.  Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors.

Authors:  Christian Hafner; Agustí Toll; Alejandro Fernández-Casado; Julie Earl; Miriam Marqués; Francesco Acquadro; Marinela Méndez-Pertuz; Miguel Urioste; Núria Malats; Julie E Burns; Margaret A Knowles; Juan C Cigudosa; Arndt Hartmann; Thomas Vogt; Michael Landthaler; Ramón M Pujol; Francisco X Real
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.

Authors:  Jingyuan Tang; Xiao Li; Xuping Jiang; Weizhang Xu; Zhen Xu; Wei Wang; Bianjiang Liu; Qiang Lv; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Authors:  Thorunn Rafnar; Sita H Vermeulen; Patrick Sulem; Gudmar Thorleifsson; Katja K Aben; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; Christina A Hulsbergen-van de Kaa; Soren Besenbacher; Daniel Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Hrefna Johannsdottir; Hjordis Bjarnason; Carlo Zanon; Hafdis Helgadottir; Jon Gunnlaugur Jonasson; Laufey Tryggvadottir; Eirikur Jonsson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; D Timothy Bishop; Sei Chung-Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Margaret A Knowles; Petra J de Verdier; Charlotta Ryk; Annika Lindblom; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Angeles Panadero; José I Sanz-Velez; Manuel Sanchez; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Silvia Selinski; Holger Gerullis; Daniel Ovsiannikov; Abdolaziz Khezri; Alireza Aminsharifi; Mahyar Malekzadeh; Leonard H van den Berg; Roel A Ophoff; Jan H Veldink; Maurice P Zeegers; Eliane Kellen; Jacopo Fostinelli; Daniele Andreoli; Cecilia Arici; Stefano Porru; Frank Buntinx; Abbas Ghaderi; Klaus Golka; José I Mayordomo; Giuseppe Matullo; Rajiv Kumar; Gunnar Steineck; Anne E Kiltie; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Lambertus A Kiemeney
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

4.  Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.

Authors:  Roman Corral; Juan Pablo Lewinger; David Van Den Berg; Amit D Joshi; Jian-Min Yuan; Manuela Gago-Dominguez; Victoria K Cortessis; Malcolm C Pike; David V Conti; Duncan C Thomas; Christopher K Edlund; Yu-Tang Gao; Yong-Bing Xiang; Wei Zhang; Yu-Chen Su; Mariana C Stern
Journal:  Int J Cancer       Date:  2014-01-13       Impact factor: 7.396

5.  Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.

Authors:  Jeanne A Pierzynski; Michelle A Hildebrandt; Ashish M Kamat; Jie Lin; Yuanqing Ye; Colin P N Dinney; Xifeng Wu
Journal:  J Urol       Date:  2015-07-11       Impact factor: 7.450

6.  Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.

Authors:  Guangwu Guo; Xiaojuan Sun; Chao Chen; Song Wu; Peide Huang; Zesong Li; Michael Dean; Yi Huang; Wenlong Jia; Quan Zhou; Aifa Tang; Zuoquan Yang; Xianxin Li; Pengfei Song; Xiaokun Zhao; Rui Ye; Shiqiang Zhang; Zhao Lin; Mingfu Qi; Shengqing Wan; Liangfu Xie; Fan Fan; Michael L Nickerson; Xiangjun Zou; Xueda Hu; Li Xing; Zhaojie Lv; Hongbin Mei; Shengjie Gao; Chaozhao Liang; Zhibo Gao; Jingxiao Lu; Yuan Yu; Chunxiao Liu; Lin Li; Xiaodong Fang; Zhimao Jiang; Jie Yang; Cailing Li; Xin Zhao; Jing Chen; Fang Zhang; Yongqi Lai; Zheguang Lin; Fangjian Zhou; Hao Chen; Hsiao Chang Chan; Shirley Tsang; Dan Theodorescu; Yingrui Li; Xiuqing Zhang; Jian Wang; Huanming Yang; Yaoting Gui; Jun Wang; Zhiming Cai
Journal:  Nat Genet       Date:  2013-10-13       Impact factor: 38.330

7.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Authors:  Montserrat Garcia-Closas; Yuanqing Ye; Nathaniel Rothman; Jonine D Figueroa; Núria Malats; Colin P Dinney; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Zhaoming Wang; Jie Lin; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jian Gu; Xia Pu; Amy Hutchinson; Yi-Ping Fu; Laurie Burdett; Meredith Yeager; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock; Xifeng Wu
Journal:  Hum Mol Genet       Date:  2011-08-08       Impact factor: 6.150

8.  Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.

Authors:  Meilin Wang; Haiyan Chu; Fu Yan; Chao Qin; Pu Li; Lin Yuan; Changjun Yin; Jianfeng Xu; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

9.  Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.

Authors:  Alexandra Masson-Lecomte; Evangelina López de Maturana; Michael E Goddard; Antoni Picornell; Marta Rava; Anna González-Neira; Mirari Márquez; Alfredo Carrato; Adonina Tardon; Josep Lloreta; Montserrat Garcia-Closas; Debra Silverman; Nathaniel Rothman; Manolis Kogevinas; Yves Allory; Stephen J Chanock; Francisco X Real; Núria Malats
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-06       Impact factor: 4.254

10.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Authors:  Montserrat Garcia-Closas; Nathaniel Rothman; Jonine D Figueroa; Ludmila Prokunina-Olsson; Summer S Han; Dalsu Baris; Eric J Jacobs; Nuria Malats; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Sapna Sharma; Yi-Ping Fu; Manolis Kogevinas; Zhaoming Wang; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Susan M Gapstur; Michael Thun; William Ryan Diver; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Amy Hutchinson; Laurie Burdett; Kevin B Jacobs; Meredith Yeager; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.